Trial Identifier: | D1690R00007 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02695121 |
Start Date: | January 2017 |
Primary Completion Date: | December 2024 |
Study Completion Date: | December 2024 |
Condition: | Cancer - Other; Breast Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Netherlands | Utrecht, Netherlands |
United Kingdom | London, United Kingdom |
United States of America, DE | Wilmington, DE, United States of America |
United States of America, Washington DC | Washington DC, United States of America |
USA, DE | Wilmington, DE, USA |
USA, Washington DC | Washington DC, USA |